Review: immunosuppression for the lung transplant patient

Lung transplantation (LTx) has evolved significantly since its inception and the improvement in LTx outcomes over the last three decades has predominantly been driven by advances in immunosuppression management. Despite the lack of new classes of immunosuppression medications, immunosuppressive stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotecha, Sakhee, Ivulich, Steven, Snell, Gregory
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Lung Transplantation: Past, Present, and Future
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662512/
https://www.ncbi.nlm.nih.gov/pubmed/34992841
http://dx.doi.org/10.21037/jtd-2021-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662512/
https://www.ncbi.nlm.nih.gov/pubmed/34992841
http://dx.doi.org/10.21037/jtd-2021-11

Ejemplares similares